Hunfelden-Dauborn, Germany

Markus Bleich


 

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 162(Granted Patents)


Location History:

  • Hünfelden-Dauborn, DE (2002 - 2005)
  • Hunfelden-Dauborn, DE (2006 - 2010)

Company Filing History:


Years Active: 2002-2010

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor Profile: Markus Bleich from Hunfelden-Dauborn, DE

Introduction

Markus Bleich is a notable inventor based in Hunfelden-Dauborn, Germany, recognized for his significant contributions to pharmaceutical innovations. With an impressive portfolio of 12 patents, Bleich has made substantial strides in the fields of disease treatment and diagnosis, particularly in metabolic diseases and central nervous system disorders.

Latest Patents

Among his latest innovations, Bleich has developed two noteworthy patents. The first one focuses on "Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis." This invention involves compounds comprising substituted thiophene derivatives designed to treat a variety of disorders, including respiratory disorders, ischemic and proliferative events, central nervous system issues, diabetes, and infections by parasites. The second patent discusses the "Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy, and advanced glycation end-product associated diseases." This invention outlines the application of vasopeptidase inhibitors for treating nephropathy in non-diabetic patients, showcasing Bleich's commitment to addressing complex health challenges.

Career Highlights

Markus Bleich has collaborated with prominent companies such as Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH, where he contributed to pharmaceutical research and product development. His work in these organizations has been pivotal in advancing health-related innovations and therapies.

Collaborations

Throughout his career, Bleich has worked alongside esteemed colleagues, including Armin Hofmeister and Uwe Heinelt. These collaborations have further enhanced his capacity to innovate and develop effective solutions for various medical conditions.

Conclusion

Markus Bleich stands out as an influential inventor in the pharmaceutical sector. His dedication to improving health outcomes through innovative treatments highlights the impact of intellectual contributions on society. With a robust patent portfolio and collaborative spirit, Bleich continues to pave the way for advancements in medical science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…